Published by Josh White on 9th October 2023
(Sharecast News) - Biotechnology company Sareum Holdings reported a loss of £3.2m after tax in its final results on Monday, widening from last year's £2.2m due to heightened expenses from initiating clinical studies with SDC-1801, despite aligning with market anticipations.
URL: http://www.digitallook.com/dl/news/story/33823783/...